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Expression of the human immunodeficiency virus type 1 (HIV-1) Env glycoprotein is stringently regulated
in infected cells. The majority of the glycoprotein does not reach the cell surface but rather is retained in the
endoplasmic reticulum or a cis-Golgi compartment and subsequently degraded. We here report that Env of
various HIV-1 isolates is ubiquitinated at the extracellular domain of gp41 and that Env expression could be
increased by lactacystin, a specific proteasome inhibitor, suggesting that the ubiquitin/proteasome system is
involved in control of expression and degradation.
The human immunodeficiency virus type 1 (HIV-1) enve-
lope glycoprotein gp160 is produced as a precursor polypro-
tein, which is cleaved in a Golgi or post-Golgi compartment by
a cellular furin-type protease into gp120 and gp41 subunits (13,
19, 22, 25, 26). Although Env cleavage efficacy during its trans-
port through the secretory pathway depends on both cell type
and virus isolate, it is very inefficient; the majority of the Env
glycoproteins remain uncleaved and retained in the endoplas-
mic reticulum (ER) or a cis-Golgi compartment (8). Accord-
ingly, the majority of the gp160 glycoproteins remain endogly-
cosidase H sensitive, which is indicative of proteins that do not
reach the medial Golgi (14, 27). Retained and probably mis-
folded Env is subsequently degraded, which was reported to
occur in either lysosomes (31) or a Golgi-associated compart-
ment (14). However, the current view of protein degradation
holds that lysosomes are reached through either endosomes or
late Golgi compartments.
The ER is the entry site of proteins into the secretory path-
way. It is responsible for proper folding of proteins before
transport to the cis-Golgi compartment and acts to ensure that
misfolded and nonassembled proteins are eliminated (re-
viewed in references 10 and 15). Recently, the ubiquitin/pro-
teasome system located in the cytoplasm was identified as the
major site of degradation for ER-resident proteins as well as
proteolytic substrates of the secretory pathway destined for
degradation (3, 28). Proteolytic degradation of these proteins
appears to be preceded by a retrograde transport to the cytosol
(17, 30). Recently, it was reported that the chaperone GRB78
BiP is linked to this retrograde protein translocation for ER
degradation (12, 18, 23). In HIV-infected cells, GRB78 BiP
was shown to bind to Env (9) together with other ER-based
chaperones including calnexin (16, 21) and calreticulin (21). As
the majority of Env is retained in the ER and subsequently
degraded without reaching late Golgi compartments, we asked
whether the ubiquitin/proteasome system is involved in HIV-1
Env degradation and whether ubiquitinated Env can be de-
tected in infected cells.
First, we tested whether Env glycoprotein of the MN isolate
can be reprecipitated using antiubiquitin and anti-Env antibod-
ies (Fig. 1a). Upon sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) Env glycoprotein was detected
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FIG. 1. Env from various HIV-1 subtypes is ubiquitinated. (a) 293T cells
transiently transfected with Env MN were pulsed for 1 h with [35S]Cys-Met,
lysed, and precipitated with either polyclonal antiserum U5379 against ubiquitin
(Sigma, St. Louis, Mo.), a human antiserum detecting HIV-1 Env (95-2), or an
irrelevant antiserum. Subsequently, lysates were reprecipitated with either of the
three antibodies and analysed by SDS-PAGE (8% gel) and autoradiography. The
numbers 1 and 2 refer to the sequential order of precipitation. (b) Ubiquitinated
Env of cells metabolically labeled for 1 h with [35S]Cys-Met can be detected by
precipitation using monoclonal antibody 2C5 (Calbiochem, La Jolla, Calif.) or
polyclonal antisera SPA-200 (Stressgene, Victoria, British Columbia, Canada)
and U5379 (Sigma) against ubiquitin and reprecipitation with anti-Env. (c) 293T
cells were either infected with recombinant vaccinia virus (NIBSC/MRC AIDS
Reagent Project) expressing Env of the 92UG037 (subtype A), 92BR020 (sub-
type B), or 92BR025 (subtype C) isolates or transiently transfected with a plas-
mid expressing Env of the MN (subtype B) isolate (1). Cell lysates of cells
metabolically labeled for 1 h with [35S]Cys-Met were either precipitated with
human antiserum 95-2 against HIV-1 or first precipitated with polyclonal serum
U5379 against ubiquitin and reprecipitated with antiserum 95-2 (derived from an
HIV-1-infected individual). Immunoprecipitates were subjected to SDS-PAGE
on an 8% gel. (d) Cells transiently transfected with Env MN were labeled for 1 h
with [35S]Cys-Met, lysed, and precipitated with either antiserum 95-2 or poly-
clonal antiserum U5379 and subsequently reprecipitated with 95-2. The im-
munoprecipitates were either digested with PNGase F (Roche, Mannheim,
Germany) (gp160p) overnight or left untreated (gp160) and subjected to elec-
trophoresis.
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independently of the sequential order of precipitation if anti-
ubiquitin and anti-Env antibodies were used, but not if either
of the two antibodies was replaced by an irrelevant antibody.
To exclude that cross-reactivity of the antiubiquitin antibody
caused this result, we tested three different commercially avail-
able mono- and polyclonal antibodies (Fig. 1b). As shown with
Env 92BR020, all three antibodies were able to reprecipitate
Env, indicating specific recognition of the antigen. Subse-
quently, we tested glycoproteins of different HIV-1 isolates
expressed by either recombinant vaccinia virus or transient
transfection with Env expression plasmids for ubiquitination
(Fig. 1c). Env glycoproteins from all HIV-1 isolates tested,
including MN (subtype B) and the primary isolates 92UG037
(subtype A), 92BR020 (subtype B), and 92BR025 (subtype C),
were found to be ubiquitinated. Moreover, ubiquitinated Env
was precipitated from 293T kidney carcinoma cells (Fig. 1), as
well as C8166 and Jurkat T lymphocytes, indicating that ubiq-
uitination of Env is not cell type specific (data not shown).
Although the molecular weight was difficult to evaluate due to
high glycosylation, we could detect no major differences in size
between total Env and ubiquitinated Env, suggesting that only
a single ubiquitin molecule (8.4 kDa) had been added. To
evaluate the number of ubiquitin residues linked to the glyco-
protein, we treated the immunoprecipitates with peptide N-
glycosidase (PNGase F), which completely removes carbohy-
drate moieties (Fig. 1d). A size difference of approximately 8
kDa corresponding to one ubiquitin molecule could be de-
tected between deglycosylated total and ubiquitinated Env. No
ubiquitinated Env could be found within total deglycosylated
Env, probably reflecting the low quantity of the ubiquitinated
form in relation to total Env.
Misfolded soluble and membrane proteins in the ER are
dislocated to the cytosolic proteolytic system by retrograde
transport, in which at least for some proteins components of
the Sec61 translocon and the proteasome appear to be in-
volved (17, 30). We thus tested by particulate fraction experi-
ments whether ubiquitinated Env is membrane associated or
can be found in the cytosol (Fig. 2). Transfected 293T cells
were metabolically labeled for 1 h and chased for 0 and 5 h.
Cells were disrupted and separated into membrane and cyto-
solic fractions by centrifugation. After both 0 and 5 h of chase,
ubiquitinated Env was found only in the membrane (pellet),
not in the cytosolic fraction (supernatant). Due to the low Env
cleavage efficiency in 293T cells, almost no gp120 could be
detected even after 5 h of chase. To control for proper frac-
tionation, major histocompatibility complex (MHC) class I
molecules were precipitated from both fractions. As previously
reported, MHC class I molecules were precipitated from the
membrane but not in the cytosolic fraction under the condi-
tions used (30). Therefore, we have no evidence for a contam-
ination of the two fractions and conclude that the main portion
of ubiquitinated Env is still membrane bound and not located
within the cytosol in soluble form. Addition of lactacystin, a
specific proteasome inhibitor, increased the amount of both
Env and ubiquitinated Env after 0 and 5 h of chase (Fig. 2).
Thus, these data suggest that ubiquitinated Env is at least
partly degraded by proteasomes and that Env is ubiquitinated
prior to translocation into the cytosol.
Ubiquitin is usually attached to lysine residues in long poly-
meric chains (7, 11) but can also be detected in monoubiquitin-
ated (20, 29) and in lysineless proteins (5, 6). To determine the
site of ubiquitination, C-terminal Env deletion mutants were
tested by reprecipitation with antiubiquitin and anti-Env anti-
bodies (Fig. 3a and b). Ubiquitinated Env MN was detected in
transfected 293T cells after a 1-h pulse if gp160, gp140Dcyt, or
gp130Dtm was expressed, but not for gp120, suggesting that
ubiquitin is bound to the extracellular part of gp41. Further
evidence for this binding site was received by proteinase K
digest of isolated microsomes from 293T cells expressing Env
(Fig. 3c). Ubiquinated Env was detected by reprecipitation in
undigested as well as in proteinase K-digested microsomes,
indicating that proteolytic deletion of the cytoplasmic Env do-
main does not disrupt ubiquitination. Since we were not able to
detect the proteinase K-digested Env protein by Western blot
analysis with monoclonal antibody 1577 directed against resi-
dues 735 to 752 of gp41, the cytoplasmic gp41 domain had
been completely degraded (Fig. 3d). Sequence comparison
between the four ubiquitinated Env glycoproteins shown in
Fig. 1 revealed three conserved lysine residues as potential
sites of ubiquitination. Our results indicating that ubiquiti-
nated Env is still membrane associated and that ubiquitin is
bound to the extracellular, luminal part of gp41 suggest that
ubiquitination, translocation, and ER degradation of Env con-
stitute an integrated process, as recently discussed for other
luminal and integral membrane proteins (4, 24). To test
whether ubiquitinated Env can also be detected in HIV-1-
infected cells, we metabolically labeled C8166 cells infected
with either HIV-1 MN or HIV-1 MvP 899 and reprecipitated
cell lysates with antiubiquitin and anti-Env antisera (Fig. 4). In
accordance with the experiments shown in Fig. 3, mapping the
ubiquitination site, we detected ubiquitinated gp160 but not
gp120 in cells infected with both HIV-1 isolates.
In this study, we showed that the extracellular domain of
HIV-1 gp41 is ubiquitinated. Since the proteasome inhibitor
lactacystin increased the amount of Env, we assume that ubiq-
uitination occurs prior to degradation in the proteasome. This
is consistent with and might explain observations by us and
other groups that the majority of Env molecules are retained in
FIG. 2. Ubiquitinated Env is membrane associated, and its expression is
increased by proteasome inhibitors. Transiently transfected 293T cells expressing
Env MN were pulsed for 1 h with [35S]Cys-Met and subsequently chased for 0
and 5 h. Cells were pretreated with 5 mM lactacystin (1) or culture medium
alone (2) for 1 h. Lactacystin was also present during the pulse and chase
periods. Cells were detached with 1 mM EDTA–phosphate-buffered saline
(PBS) and resuspended in hypotonic buffer (10 mM HEPES, 10 mM KCl, 10 mM
MgCl2 [pH 7.6]). Subsequently, cells were disrupted using a 25-gauge syringe,
nuclei were removed by centrifugation at 1,000 3 g for 10 min, and membrane
(m) and cytosolic (c) fractions were isolated by centrifugation at 20,000 3 g for
15 min. The pellet was resuspended and washed once in hypotonic buffer. The
lysates were split and either precipitated with human antiserum 95-2 against
HIV-1 (a), first precipitated with a polyclonal serum against ubiquitin (U5379)
and reprecipitated with antiserum 95-2 (b), or precipitated with a monoclonal
antibody against MHC class I (W6/32) (c). Immunoprecipitates were subjected
to electrophoresis on either an 8% (gp160) or 12% (MHC class I) gel.
5374 NOTES J. VIROL.
the ER and stay endoglycosidase H sensitive (14, 27). Intrigu-
ingly, recent reports suggested alternative explanations for ubi-
quitinated viral proteins. It was shown that p6gag of HIV-1 and
simian immunodeficiency virus, as well as p12gag of murine
leukemia virus and US9 of herpes simplex virus type, 1 are
ubiquitinated and can be found within virus particles, in addi-
tion to free ubiquitin (2, 5, 20). The significance of ubiquiti-
nated viral proteins thus remains unclear. Ubiquitinated viral
proteins might have escaped from degradation by the protea-
some in cells with high levels of viral proteins. Alternatively, it
has been suggested that ubiquitinated viral proteins have spe-
cific roles in viral pathogenesis using the host cell ubiquitin/
proteasome machinery (5, 20).
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